JPWO2022177029A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022177029A5
JPWO2022177029A5 JP2023500976A JP2023500976A JPWO2022177029A5 JP WO2022177029 A5 JPWO2022177029 A5 JP WO2022177029A5 JP 2023500976 A JP2023500976 A JP 2023500976A JP 2023500976 A JP2023500976 A JP 2023500976A JP WO2022177029 A5 JPWO2022177029 A5 JP WO2022177029A5
Authority
JP
Japan
Prior art keywords
coronavirus
selenoneine
tautomer
dimer
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023500976A
Other languages
English (en)
Japanese (ja)
Other versions
JP7837513B2 (ja
JPWO2022177029A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/007397 external-priority patent/WO2022177029A1/ja
Publication of JPWO2022177029A1 publication Critical patent/JPWO2022177029A1/ja
Publication of JPWO2022177029A5 publication Critical patent/JPWO2022177029A5/ja
Application granted granted Critical
Publication of JP7837513B2 publication Critical patent/JP7837513B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023500976A 2021-02-22 2022-02-22 セレノネインを含む、ｃｏｖｉｄ１９治療又は予防薬 Active JP7837513B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2021026585 2021-02-22
JP2021026585 2021-02-22
JP2021106076 2021-06-25
JP2021106076 2021-06-25
JP2021165803 2021-10-07
JP2021165803 2021-10-07
PCT/JP2022/007397 WO2022177029A1 (ja) 2021-02-22 2022-02-22 セレノネインを含む、ｃｏｖｉｄ１９治療又は予防薬

Publications (3)

Publication Number Publication Date
JPWO2022177029A1 JPWO2022177029A1 (https=) 2022-08-25
JPWO2022177029A5 true JPWO2022177029A5 (https=) 2024-12-24
JP7837513B2 JP7837513B2 (ja) 2026-03-31

Family

ID=82931986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023500976A Active JP7837513B2 (ja) 2021-02-22 2022-02-22 セレノネインを含む、ｃｏｖｉｄ１９治療又は予防薬

Country Status (4)

Country Link
US (1) US20250352517A1 (https=)
JP (1) JP7837513B2 (https=)
TW (1) TWI911391B (https=)
WO (1) WO2022177029A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115737675B (zh) * 2022-11-28 2024-03-08 安徽农业大学 氧化型硒代硫酸钠的制备及其在治疗冠状病毒感染中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11504355B2 (en) * 2018-03-05 2022-11-22 Mironova Innovations, Llc Ergothioneine compositions and methods for maintaining and/or increasing vitamin C levels in cells and organisms

Similar Documents

Publication Publication Date Title
ZA202209563B (en) Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors
EA202191286A1 (ru) Ингибитор 15-pgdh
EA202191991A1 (ru) Новые производные гетеротрициклического соединения и их применение
GEAP202416435A (en) Anti-viral compounds
EA202092168A1 (ru) Применение фавипиравира в лечении коронавирусной инфекции
DK1414494T3 (da) Hæmmende antistoffer af HER3-aktivitet
MX2021010133A (es) Forma cristalina de 1-(1-oxo-1,2-dihidroisoquinolin-5-il)-5-(trifl uorometil)-n-(2-(trifluorometil)piridin-4-il)-1h-pirazol-4-carbox amida monohidratada.
JOP20210338A1 (ar) نظائر 3-(5-مثيل-3،1- ثيازول-2- يل)-n-{(1r)-1-[2-(تراي فلورومثيل) بيريميدين-5-يل] إثيل} بنزاميد
JP2022510303A5 (https=)
MX2022012881A (es) Inhibidores de replicacion del virus de inmunodeficiencia humana.
MX2022015679A (es) Inhibidor de tyk-2.
JPWO2022177029A5 (https=)
JP2019151627A5 (https=)
CL2024001073A1 (es) Inhibidores de la replicación del virus de inmunodeficiencia humana
CN115666576A (zh) 一种治疗和/或预防冠状病毒引发的疾病的化合物及其应用
MX2025012370A (es) Compuesto de amida, composicion farmaceutica que comprende el compuesto y uso de esta
DK1206444T3 (da) Forbindelser der hæmmer tryptaseaktivitet
MX2024008507A (es) Combinacion de 8-cloro-n-(4-(trifluorometoxi)fenil)quinolin-2-amin a y sus derivados con un inhibidor de janus cinasa (jak).
JP2008513426A5 (https=)
CL2022002490A1 (es) Derivados de biarilo como inhibidores de la interacción proteína-proteína de yap/taz-tead
JP2008513427A5 (https=)
JOP20240183A1 (ar) مثبطات بروتين رابط لإموباميل واستخداماتها
CN113286798A (zh) 内环硫脒酰胺-芳基酰胺类化合物及其治疗乙型肝炎的用途
JP2020043851A5 (https=)
MX2020009287A (es) Nuevo compuesto y composicion farmaceutica que lo comprende.